Citation 14655

LIU,J: BURDETTE,JE: SUN,Y: DEN,S: SCHLECHT,SM: ZHENG,W: NIKOLIC,D: MAHADY,G: VAN BREEMEN,RB: FONG,HHS: PEZZUTO,JM: BOLTON,JL: FARNSWORTH,NR:. (2004). ISOLATION OF LINOLEIC ACID AS AN ESTROGENIC COMPOUND FROM THE FRUITS OF VITEX AGNUS-CASTUS L. (CHASTE-BERRY).. 11(1)

Citation Details

Title	ISOLATION OF LINOLEIC ACID AS AN ESTROGENIC COMPOUND FROM THE FRUITS OF VITEX AGNUS-CASTUS L. (CHASTE-BERRY).
Authors	LIU,J: BURDETTE,JE: SUN,Y: DEN,S: SCHLECHT,SM: ZHENG,W: NIKOLIC,D: MAHADY,G: VAN BREEMEN,RB: FONG,HHS: PEZZUTO,JM: BOLTON,JL: FARNSWORTH,NR:
Year	2004
Volume	11
Issue	1

Summary

Year: 2004

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LINOLENIC ACID	ACTIVE
2	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LINOLENIC ACID	WEAK ACTIVITY
3	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEIC ACID	ACTIVE
4	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEIC ACID	ACTIVE
5	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ERUCIC ACID	ACTIVE
6	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ERUCIC ACID	ACTIVE
7	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMITOLEIC ACID	WEAK ACTIVITY
8	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMITOLEIC ACID	ACTIVE
9	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ARACHIDIC ACID	WEAK ACTIVITY
10	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ARACHIDIC ACID	WEAK ACTIVITY
11	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	STEARIC ACID	INACTIVE
12	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	STEARIC ACID	WEAK ACTIVITY
13	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAPRIC ACID	INACTIVE
14	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAPRIC ACID	INACTIVE
15	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LAURIC ACID	INACTIVE
16	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LAURIC ACID	INACTIVE
17	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMITIC ACID	ACTIVE
18	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PALMITIC ACID	WEAK ACTIVITY
19	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ARACHIDONIC ACID	WEAK ACTIVITY
20	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ARACHIDONIC ACID	ACTIVE
21	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DOCOSAHEXAENOIC ACID	ACTIVE
22	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DOCOSAHEXAENOIC ACID	ACTIVE
23	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	NERVONIC ACID	ACTIVE
24	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	NERVONIC ACID	WEAK ACTIVITY
25	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ELAIDIC ACID	ACTIVE
26	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ELAIDIC ACID	ACTIVE
27	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROSELINIC ACID	ACTIVE
28	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PETROSELINIC ACID	ACTIVE
29	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BEHENIC ACID	WEAK ACTIVITY
30	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BEHENIC ACID	INACTIVE
31	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LIGNOCERIC ACID	WEAK ACTIVITY
32	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LIGNOCERIC ACID	INACTIVE
33	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTIC ACID	ACTIVE
34	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRISTIC ACID	WEAK ACTIVITY
35	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAPROIC ACID	WEAK ACTIVITY
36	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAPROIC ACID	INACTIVE
37	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAPRYLIC ACID	WEAK ACTIVITY
38	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAPRYLIC ACID	INACTIVE

Vitex agnus-castus (LAMIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OF	LINOLEIC ACID	None
5	ESTROGEN RECEPTOR(ALPHA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LINOLEIC ACID	ACTIVE
6	ESTROGEN RECEPTOR(BETA) BINDING EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	LINOLEIC ACID	ACTIVE